These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 1282103)
1. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices. Suarez-Roca H; Maixner W Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103 [TBL] [Abstract][Full Text] [Related]
2. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. Suarez-Roca H; Maixner W J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733 [TBL] [Abstract][Full Text] [Related]
3. Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes. Suarez-Roca H; Maixner W Brain Res; 1992 May; 579(2):195-203. PubMed ID: 1378347 [TBL] [Abstract][Full Text] [Related]
4. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat. Wang XM; Yan JQ; Zhang KM; Mokha SS Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156 [TBL] [Abstract][Full Text] [Related]
6. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Lupica CR; Proctor WR; Dunwiddie TV Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320 [TBL] [Abstract][Full Text] [Related]
7. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists. Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223 [TBL] [Abstract][Full Text] [Related]
8. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
9. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. Cahill CM; White TD; Sawynok J J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600 [TBL] [Abstract][Full Text] [Related]
10. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214 [TBL] [Abstract][Full Text] [Related]
11. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors. Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189 [TBL] [Abstract][Full Text] [Related]
12. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat. Tiseo PJ; Yaksh TL Eur J Pharmacol; 1993 May; 236(1):89-96. PubMed ID: 8391455 [TBL] [Abstract][Full Text] [Related]
13. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676 [TBL] [Abstract][Full Text] [Related]
14. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485 [TBL] [Abstract][Full Text] [Related]
15. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material. Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079 [TBL] [Abstract][Full Text] [Related]
16. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN; Hogenboom F; Mulder AH Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509 [TBL] [Abstract][Full Text] [Related]
17. Depression of potassium-evoked striatal acetylcholine release by delta-receptor activation: inhibition by cholinoactive agents. Ruzicka BB; Jhamandas K Can J Physiol Pharmacol; 1988 Dec; 66(12):1487-92. PubMed ID: 2852536 [TBL] [Abstract][Full Text] [Related]